Efficacy of Sprint Interval Training on Anthropometric Measures

June 2, 2021 updated by: Imtiyaz Ali Mir, Universiti Tunku Abdul Rahman

Effectiveness of Sprint Interval Training on Anthropometric Measures Among Obese and Overweight Young Adults: A Systematic Review

Due to the rising problem of overweight and obesity, many strategies are implemented to combat this issue and one of the most common ways is exercise training. Aerobic exercise is a popular and effective conservative strategy for weight and adiposity management and commonly used exercise protocols are moderate-intensity continuous training (MICT) and interval training (IT). MICT is typically defined as continuous effort that elicits 55%-70% of the maximal heart rate or promotes oxygen consumption equivalent to 40%-60% of the maximum oxygen intake. IT involves repeated exercise with periods of recovery, which includes high intensity interval training (HIIT) and Sprint interval training (SIT). HIIT is exercising at 80% to 100% of maximal heart rate while SIT involves "all-out" or "supramaximal" effort at the intensity of 100% of maximal oxygen uptake. Multiple systematic reviews on the effect of SIT on aerobic capacity or comparisons between other forms of exercise protocols to reduce body adiposity has been conducted, but so far no systematic review has been carried out to evaluate the efficacy of this protocol solely on anthropometric measures on young obese and overweight adults alone. Hence, in this study, a systematic review of the effect of SIT on anthropometric measurements in young obese or overweight adults will be reviewed, filtered and assembled.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Keywords using "obese", "overweight", "sprint interval training", "interval training", "anthropometric measures","body mass index", "fat %" lean muscle mass will be searched through e-databases namely Pubmed (including MEDLINE), Pedro-search, Science Direct, Google Scholar, Web of Science, Scopus and Cochrane Library for the suitable original full text studies. Only randomized control trails will be included in this study and the "Tool for the assEssment of Study qualiTy and reporting in EXercise" (TESTEX) would be utilized to assess each individual study. TESTEX has been validated and is specific to exercise training. The authors wish to use TESTEX as it addresses several shortcomings that PEDro does not e.g. exercise adherence, withdrawal, relative exercise training intensity. In addition, study quality assessment of training studies is more robust with TESTEX. 2 independent evaluators will examine and screen each study for its efficacy to be included in the data analysis.

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Selangor
      • Kajang, Selangor, Malaysia, 43000
        • Universiti Tunku Abdul Rahman

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Overweight and obese young adults, aged 18-35 years, who had participated in SIT training protocol for at-least 2 weeks or more. Changes in the anthropometric measures will be assessed.

Description

Inclusion Criteria:

  • Male and female individuals aged 18-35 years old
  • Overweight individuals with a BMI of 25.0 to <30
  • Obese individuals with a BMI of 30.0 or higher
  • Original full texts with SIT as intervention, occurring 2 weeks or more

Exclusion Criteria:

  • Male and female individuals aged below 18 and above 35 years old
  • SIT as intervention, occurring less than 2 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
BMI for change
Time Frame: At baseline (before intervention begin) and post training.
At baseline (before intervention begin) and post training.
Fat % for change
Time Frame: At baseline (before intervention begin) and post training.
At baseline (before intervention begin) and post training.
Lean Muscle Mass
Time Frame: At baseline (before intervention begin) and post training.
At baseline (before intervention begin) and post training.
Waist Circumference for change
Time Frame: At baseline (before intervention begin) and post training.
At baseline (before intervention begin) and post training.
Waist to hip ratio for change
Time Frame: At baseline (before intervention begin) and post training.
At baseline (before intervention begin) and post training.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 2, 2020

Primary Completion (ACTUAL)

February 5, 2021

Study Completion (ACTUAL)

February 5, 2021

Study Registration Dates

First Submitted

November 3, 2019

First Submitted That Met QC Criteria

March 15, 2020

First Posted (ACTUAL)

March 27, 2020

Study Record Updates

Last Update Posted (ACTUAL)

June 3, 2021

Last Update Submitted That Met QC Criteria

June 2, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UMFB1002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Sprint Interval Training

Subscribe